Literature DB >> 30510040

Canadian regulations and legal ramifications for hepatic encephalopathy: a descriptive analysis.

Henry H Nguyen1, Mark G Swain1, Philip Wong1, Stephen E Congly2.   

Abstract

BACKGROUND: Hepatic encephalopathy, a form of brain dysfunction seen in the setting of liver insufficiency, negatively affects driving performance and so is both a patient and public safety issue. We aimed to review the motor vehicle codes in each Canadian province and territory relating to the reporting of patients with hepatic encephalopathy and to search a Canadian legal database for cases of motor vehicle collisions involving patients with hepatic encephalopathy.
METHODS: In this descriptive analysis, the transportation agencies of each Canadian province and territory were contacted via telephone and/or email between April and August 2017. Requirements of physicians to report medical conditions (including liver disease and hepatic encephalopathy) affecting a patient's fitness to drive were assessed. WestlawNext Canada was searched for any Canadian cases on hepatic encephalopathy and driving-related lawsuits from inception to Dec. 31, 2017.
RESULTS: Reporting of medically unfit drivers is a requirement in all Canadian provinces and territories except Alberta, Quebec and Nova Scotia. Hepatic encephalopathy, cirrhosis and advanced liver disease were not specifically identified as reportable medical conditions in any province or territory. Our search did not identify any lawsuits involving a motor vehicle collision in Canada that were made either against physicians caring for patients with hepatic encephalopathy or against such patients themselves.
INTERPRETATION: Although hepatic encephalopathy has a substantial impact on driving performance, it is not specifically identified as a reportable medical condition in Canada. Increasing awareness of the potential impact of hepatic encephalopathy on safe driving for health care providers and the public is critical. Copyright 2018, Joule Inc. or its licensors.

Entities:  

Year:  2018        PMID: 30510040      PMCID: PMC6277253          DOI: 10.9778/cmajo.20180024

Source DB:  PubMed          Journal:  CMAJ Open        ISSN: 2291-0026


  30 in total

1.  Critical flicker frequency for quantification of low-grade hepatic encephalopathy.

Authors:  Gerald Kircheis; Matthias Wettstein; Lars Timmermann; Alfons Schnitzler; Dieter Häussinger
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

2.  Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis.

Authors:  A Das; R K Dhiman; V A Saraswat; M Verma; S R Naik
Journal:  J Gastroenterol Hepatol       Date:  2001-05       Impact factor: 4.029

3.  The electroencephalograph in liver disease.

Authors:  B G PARSONS-SMITH; W H SUMMERSKILL; A M DAWSON; S SHERLOCK
Journal:  Lancet       Date:  1957-11-02       Impact factor: 79.321

Review 4.  Characteristics of minimal hepatic encephalopathy.

Authors:  Piero Amodio; Sara Montagnese; Angelo Gatta; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

5.  Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy.

Authors:  M Romero-Gómez; F Boza; M S García-Valdecasas; E García; J Aguilar-Reina
Journal:  Am J Gastroenterol       Date:  2001-09       Impact factor: 10.864

6.  Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy.

Authors:  Srinivasa Prasad; Radha K Dhiman; Ajay Duseja; Yogesh K Chawla; Arpita Sharma; Ritesh Agarwal
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

7.  Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy.

Authors:  P Sharma; B C Sharma; V Puri; S K Sarin
Journal:  J Hepatol       Date:  2007-04-09       Impact factor: 25.083

8.  Minimal hepatic encephalopathy impairs fitness to drive.

Authors:  Christian Wein; Horst Koch; Birthe Popp; Gerd Oehler; Peter Schauder
Journal:  Hepatology       Date:  2004-03       Impact factor: 17.425

9.  Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test.

Authors:  Jasmohan S Bajaj; Kia Saeian; Christine M Schubert; Muhammad Hafeezullah; Jose Franco; Rajiv R Varma; Douglas P Gibson; Raymond G Hoffmann; R Todd Stravitz; Douglas M Heuman; Richard K Sterling; Mitchell Shiffman; Allyne Topaz; Sherry Boyett; Debulon Bell; Arun J Sanyal
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

10.  An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.

Authors:  Praveen Sharma; Barjesh C Sharma; Vinod Puri; Shiv Kumar Sarin
Journal:  Eur J Gastroenterol Hepatol       Date:  2008-06       Impact factor: 2.566

View more
  1 in total

Review 1.  Proceedings from the 2018 Canadian Association for the Study of the Liver Single Topic Conference-Decompensated cirrhosis: from clinic to transplant.

Authors:  Victor Dong; Maxime Gosselin; Nishita Jagarlamudi; Beverley Kok; Mark G Swain; Jasmohan S Bajaj; Juan G Abraldes; Vladimir Marquez; R Todd Stravitz; Aldo J Montano-Loza; Manuela Merli; Phil Wong; Amanda Brisebois; Puneeta Tandon; Julia Wendon; Scott L Nyberg; François M Carrier; Michael R Lucey; Florence Wong; Jordan J Feld; Constantine J Karvellas; Christopher F Rose; Julien Bissonnette
Journal:  Can Liver J       Date:  2019-12-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.